CURCUMIN: THE INDIAN SOLID GOLD
CURCUMIN: THE INDIAN SOLID GOLD
CURCUMIN: THE INDIAN SOLID GOLD
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
P1: OTE/SPH P2: OTE<br />
SVNY332-Aggarwal December 22, 2006 16:34<br />
<strong>CURCUMIN</strong>: <strong>THE</strong> <strong>INDIAN</strong> <strong>SOLID</strong> <strong>GOLD</strong> 27<br />
204. J. F. Santibanez, M. Quintanilla, and J. Martinez, Genistein and curcumin block TGFbeta<br />
1-induced u-PA expression and migratory and invasive phenotype in mouse epidermal<br />
keratinocytes. Nutr Cancer 37, 49–54 (2000).<br />
205. R. Mohan, J. Sivak, P. Ashton, L. A. Russo, B. Q. Pham, N. Kasahara, M. B. Raizman,<br />
and M. E. Fini, Curcuminoids inhibit the angiogenic response stimulated by fibroblast<br />
growth factor-2, including expression of matrix metalloproteinase gelatinase B. J Biol<br />
Chem 275, 10,405–10,512 (2000).<br />
206. S. C. Shih and K. P. Claffey, Role of AP-1 and HIF-1 transcription factors in TGF-beta<br />
activation of VEGF expression. Growth Factors 19, 19–34 (2001).<br />
207. H. Mani, G. S. Sidhu, R. Kumari, J. P. Gaddipati, P. Seth and R. K. Maheshwari,<br />
Curcumin differentially regulates TGF-beta1, its receptors and nitric oxide synthase<br />
during impaired wound healing. Biofactors 16, 29–43 (2002).<br />
208. A. E. Gururaj, M. Belakavadi, D. A. Venkatesh, D. Marme, and B. P. Salimath, Molecular<br />
mechanisms of anti-angiogenic effect of curcumin. Biochem Biophys Res Commun<br />
297, 934–942 (2002).<br />
209. J. Gaedeke, N. A. Noble, and W. A. Border, Curcumin blocks multiple sites of the<br />
TGF-beta signaling cascade in renal cells. Kidney Int 66, 112–120 (2004).<br />
210. P. C. Smith, J. F. Santibanez, J. P. Morales, and J. Martinez, Epidermal growth factor<br />
stimulates urokinase-type plasminogen activator expression in human gingival fibroblasts.<br />
Possible modulation by genistein and curcumin. J Periodontal Res 39, 380–387<br />
(2004).<br />
211. A. Chen, J. Xu, and A. C. Johnson, Curcumin inhibits human colon cancer cell growth<br />
by suppressing gene expression of epidermal growth factor receptor through reducing<br />
the activity of the transcription factor Egr-1. Oncogene 25, 278–287 (2006).<br />
212. J. H. Kim, C. Xu, Y. S. Keum, B. Reddy, A. Conney, and A. N. Kong, Inhibition of<br />
EGFR signaling in human prostate cancer PC-3 cells by combination treatment with<br />
beta-phenylethyl isothiocyanate and curcumin. Carcinogenesis 27, 475–482 (2006).<br />
213. S. Zheng and A. Chen, Curcumin suppresses the expression of extracellular matrix<br />
genes in activated hepatic stellate cells by inhibiting gene expression of connective<br />
tissue growth factor. Am J Physiol Gastrointest Liver Physiol 290, G883–G893 (2006).<br />
214. A. Masamune, N. Suzuki, K. Kikuta, M. Satoh, K. Satoh, and T. Shimosegawa, Curcumin<br />
blocks activation of pancreatic stellate cells. J Cell Biochem 97, 1080–1093<br />
(2006).<br />
215. X. Yang, D. P. Thomas, X. Zhang, B. W. Culver, B. M. Alexander, W. J. Murdoch,<br />
M. N. Rao, D. A. Tulis, J. Ren, and N. Sreejayan, Curcumin inhibits platelet-derived<br />
growth factor-stimulated vascular smooth muscle cell function and injury-induced<br />
neointima formation. Arterioscler Thromb Vasc Biol 26, 85–90 (2006).<br />
216. Y. Takada, A. Bhardwaj, P. Potdar, and B. B. Aggarwal, Nonsteroidal antiinflammatory<br />
agents differ in their ability to suppress NF-kappaB activation, inhibition<br />
of expression of cyclooxygenase-2 and cyclin D1, and abrogation of tumor cell<br />
proliferation. Oncogene 23, 9247–9258 (2004).<br />
217. J. M. Dogne, J. Hanson, C. Supuran, and D. Pratico, Coxibs and cardiovascular sideeffects:<br />
from light to shadow. Curr Pharm Des 12, 971–975 (2006).<br />
218. A. T. Chan, J. E. Manson, C. M. Albert, C. U. Chae, K. M. Rexrode, G. C. Curhan,<br />
E. B. Rimm, W. C. Willett, and C. S. Fuchs, Nonsteroidal antiinflammatory drugs,<br />
acetaminophen, and the risk of cardiovascular events. Circulation 113, 1578–1587<br />
(2006).<br />
219. M. Hermann and F. Ruschitzka, Coxibs, non-steroidal anti-inflammatory drugs and<br />
cardiovascular risk. Intern Med J 36, 308–319 (2006).